Integrated miRNA profiling and bioinformatics analyses reveal potential causative miRNAs in gastric adenocarcinoma

Gastric cancer (GC) is one of the leading causes of cancer-related deaths throughout China and worldwide. The discovery of microRNAs (miRNAs) has provided a new opportunity for developing diagnostic biomarkers and effective therapeutic targets in GC. By performing microarray analyses of benign and malignant gastric epithelial cell lines (HFE145, NCI-N87, MKN28, RF1, KATO III and RF48), 16 significantly dysregulated miRNAs were found. 11 of these were validated by real-time qRT-PCR. Based on miRWalk online database scans, 703 potential mRNA targets of the 16 miRNAs were identified. Bioinformatic analyses suggested that these dysregulated miRNAs and their predicted targets were principally involved in tumor pathogenesis, MAPK signaling, and apoptosis. Finally, miRNA-gene network analyses identified miRNA-125b as a crucial miRNA in GC development. Taken together, these results develop a comprehensive expression and functional profile of differentially expressed miRNAs related to gastric oncogenesis. This profile may serve as a potential tool for biomarker and therapeutic target identification in GC patients.

[1]  Xiaohua Li,et al.  Survival prediction of gastric cancer by a seven-microRNA signature , 2009, Gut.

[2]  Wei Li,et al.  The expression and regulation of microRNA-125b in cancers. , 2013, Acta biochimica et biophysica Sinica.

[3]  Jeanne F. Loring,et al.  The functions of microRNAs in pluripotency and reprogramming , 2012, Nature Cell Biology.

[4]  X. Zhao,et al.  MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways , 2013, British Journal of Cancer.

[5]  F. Wang,et al.  The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer , 2013, International journal of molecular sciences.

[6]  C. Croce,et al.  MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. , 2007, JAMA.

[7]  M. Erlacher,et al.  How cell death shapes cancer , 2015, Cell Death and Disease.

[8]  M. Guerrero,et al.  MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer , 2012, Cancer.

[9]  Haoliang Zhao,et al.  MicroRNA-125b Functions as a Tumor Suppressor in Hepatocellular Carcinoma Cells , 2012, International journal of molecular sciences.

[10]  Kazuhiro Yoshida,et al.  Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. , 2010, The Lancet. Oncology.

[11]  Y. Huang,et al.  Biopsy from the base of gastric ulcer may find gastric cancer earlier. , 2011, Medical hypotheses.

[12]  B. Xiao,et al.  Differential expression of microRNA species in human gastric cancer versus non‐tumorous tissues , 2009, Journal of gastroenterology and hepatology.

[13]  Diagnostic accuracy of circulating tumor cells detection in gastric cancer: systematic review and meta-analysis , 2013, BMC Cancer.

[14]  L. Miao,et al.  Underexpressed CNDP2 Participates in Gastric Cancer Growth Inhibition through Activating the MAPK Signaling Pathway , 2014, Molecular medicine.

[15]  S. Meltzer,et al.  MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro , 2011, Oncogene.

[16]  G. Johnson,et al.  Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases , 2002, Science.

[17]  V. Narry Kim,et al.  Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer , 2009, Nucleic acids research.

[18]  Jianguo G. Wu,et al.  MiR-125b promotes cell migration and invasion by targeting PPP1CA-Rb signal pathways in gastric cancer, resulting in a poor prognosis , 2015, Gastric Cancer.

[19]  E. Olson,et al.  MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles , 2012, Nature Reviews Drug Discovery.

[20]  Christopher P Evans,et al.  An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells , 2007, Proceedings of the National Academy of Sciences.

[21]  P. Brousset,et al.  Myeloid Cell Differentiation Arrest by Mir-125b-1 in Myelodysplasic Syndrome and Acute Myeloid Leukemia with the T(2;11)(p21;q23) Translocation , 2008 .

[22]  C. Croce,et al.  Clinical Applications for microRNAs in Cancer , 2013, Clinical pharmacology and therapeutics.

[23]  S. Lowe,et al.  The microcosmos of cancer , 2012, Nature.

[24]  Tian Xia,et al.  Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer , 2013, Cancer.

[25]  Jian Wang,et al.  MiR‐145, miR‐133a and miR‐133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer , 2014, FEBS letters.

[26]  Norbert Gretz,et al.  miRWalk - Database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes , 2011, J. Biomed. Informatics.

[27]  M. Seto,et al.  MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. , 2010, Cancer research.

[28]  Ning Zhang,et al.  MicroRNA‐106a targets TIMP2 to regulate invasion and metastasis of gastric cancer , 2014, FEBS letters.

[29]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[30]  Shan Wang,et al.  Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer. , 2005, World journal of gastroenterology.

[31]  C. Croce,et al.  MicroRNA deregulation in human thyroid papillary carcinomas. , 2006, Endocrine-related cancer.

[32]  Carol Friedman,et al.  PhenoGO: an integrated resource for the multiscale mining of clinical and biological data , 2009, BMC Bioinformatics.

[33]  Z. Wang,et al.  Upregulated miR‐106a plays an oncogenic role in pancreatic cancer , 2014, FEBS letters.

[34]  M. Rugge,et al.  The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis. , 2013, Human pathology.

[35]  Manuel A. S. Santos,et al.  Lack of microRNA‐101 causes E‐cadherin functional deregulation through EZH2 up‐regulation in intestinal gastric cancer , 2012, The Journal of pathology.

[36]  S. Choi,et al.  Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma , 2013, Journal of surgical oncology.